Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-31 @ 2:48 AM
Study NCT ID:
NCT02726503
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2016-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-29
First Submit QC Date:
None
Study First Post Date:
2016-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-16
Last Update Post Date:
2020-06-17
Last Update Post Date Type:
ACTUAL